Skip to main content

Abstract

Advances in the second part of this century have provided relatively satisfactory basic understanding, clinical classification, and guidelines for the management of hyperuricemia and gout. However, gout remains a significant health problem in many populations and several clinical problems have emerged to challenge clinicians, such as the atypical features and increasing prevalence of gout in elderly men and women, and the frequently aggressive course of cyclosporine induced gout.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Terkeltaub RA. Gout:questions that still need to be answered. Ann Rheum Dis 1995; 54: 79–81.

    Article  PubMed  CAS  Google Scholar 

  2. Duncan H, Dixon AS. Gout, familial hyperuricemia, and renal disease. Q J Med 1960; 29: 127–35.

    PubMed  CAS  Google Scholar 

  3. Farebrother DA, Pincott JR, Simmonds HA, Warren DJ, Dillon MJ, Cameron JS. Uric acid crystal-induced nephropathy:Evidence for a specific renal lesion in a gouty family. J Pathol 1981; 135: 159–68.

    Article  PubMed  CAS  Google Scholar 

  4. Leumann EP, Wegmann W. Familial nephropathy with hyperuricemia and gout. Nephron 1983; 34: 51–7.

    Article  PubMed  CAS  Google Scholar 

  5. Calabrese G, Simmonds HA, Cameron JS, Davies PM. Precocious familial gout with reduced fractional urate clearance and normal purine enzymes. Q J Med 1990; 75: 441–50.

    PubMed  CAS  Google Scholar 

  6. Puig JG, Miranda ME, Mateos FA, Picazo ML, Jiménez ML, Calvin TS, Gil AA. Hereditary nephropathy associated with hyperuricemia and gout. Arch Intern Med 1993; 153: 357–65.

    Article  PubMed  CAS  Google Scholar 

  7. Moro F, Ogg C, Simmonds HA, et al. Familial juvenile gouty nephropathy with renal urate hypoexcretion preceding renal damage. Clin Nephrol. 1991;35: 263–69.

    PubMed  CAS  Google Scholar 

  8. Beck LH. Requiem for gouty nephropathy. Kidney Int 1986; 30: 280–7.

    Article  PubMed  CAS  Google Scholar 

  9. Yu T, Berger L. Impaired renal function in gout. Am J Med 1982; 72: 95–100.

    Article  PubMed  CAS  Google Scholar 

  10. Berger L, Yu T. Renal functin in gout. IV. An analysis of 524 gouty subjects including long-term follow-up studies. Am J Med 1975; 59: 605–13.

    Article  PubMed  CAS  Google Scholar 

  11. Facchini F, Chen Y-DI, Hollenbeck CB, Reaven GM. Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration. JAMA 1991; 266: 3008–11.

    Article  PubMed  CAS  Google Scholar 

  12. Cappuccio FP, Strazzullo P, Farinaro E, Trevisan M. Uric acid metabolism and tubular sodium handling. Results from a population-based study. JAMA 1993; 270: 354–9.

    Article  PubMed  CAS  Google Scholar 

  13. DeFronzo RA, Cooke CR, Andres R, Faloona GR, Davis PJ. The effect of insulin on renal handling of sodium, potassium, calcium, and phosphate in man. J Clin Invest 1975; 55: 845–55.

    Article  Google Scholar 

  14. DeFronzo RA. The effect of insulin on renal sodium metabolism. Diabetologia 1981; 21: 165–71.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer Science+Business Media New York

About this chapter

Cite this chapter

Puig, J.G. et al. (1998). Gout New Questions for an Ancient Disease. In: Griesmacher, A., Müller, M.M., Chiba, P. (eds) Purine and Pyrimidine Metabolism in Man IX. Advances in Experimental Medicine and Biology, vol 431. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-5381-6_1

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-5381-6_1

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-7456-5

  • Online ISBN: 978-1-4615-5381-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics